Health & Biotech Strong interest for Compass Cannabis’ $2m cap raise kick-off July 2, 2020 Special Report: Compass Cannabis launches its equity crowdfunded cap raise today on the back of strong interest from professional and… MedAdvisor eyes off US health insurance market with new distribution deal July 1, 2020 Medtech company MedAdvisor (ASX:MDR) had some deal-flow this morning, announcing a partnership with NASDAQ-listed HMS Holdings Corp. The three-year agreement… COVID-19 adds $9bn to top four ASX health stocks July 1, 2020 That COVID-19 has been wonderful for pharmaceutical companies is not in doubt, but it hasn't been quite so good for… The elective surgery stocks getting a boost from the easing of COVID-19 restrictions July 1, 2020 Since restrictions on elective surgery were lifted, some stocks in the elective surgery space have seen windfalls that may cancel… Health: Amplia really gives a FAK about cancer as phase 1 trial still on track June 30, 2020 Amplia Therapeutics (ASX:ATX) stock is rising today after the biotech said nothing has come up in toxicology studies to stop… Health: Immutep has dosed the last patient in one of its cancer studies June 29, 2020 Cancer therapeutics biotech Immutep (ASX:IMM) has enrolled and dosed the last patient for a segment of its phase 2 study… Respiri signs key deal with UK research centre as it prepares for European launch June 26, 2020 Special Report: The agreement will see data from Respiri’s propriety wheezo technology collated to improve outcomes for asthma research. For… Check up: Diarrhoea and the FDA are lifting share prices June 25, 2020 Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 134-odd small cap health stocks… Weed Week: Local police just made an unusual discovery in a Nottingham forest June 25, 2020 For ASX investors, the focus remains on which companies can execute within Australia's tightly-regulated medicinal cannabis sector. But for this… ASX investors super happy that FDA may approve first new contraceptive pill in 11 years June 24, 2020 The powerful US drugs regulator has opened the door to a new contraceptive pill from Australian company Mayne Pharma (ASX:MYX),… Next» « Previous